Hiromi Iwasaki Selected Research

Essential Thrombocythemia

1/2017	Identification of unipotent megakaryocyte progenitors in human hematopoiesis.
1/2016	Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiromi Iwasaki Research Topics

Disease

14	Multiple Myeloma 03/2024 - 06/2010
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2022 - 06/2004
11	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2019 - 01/2010
9	Lymphoma (Lymphomas) 01/2023 - 03/2012
9	Leukemia 01/2017 - 10/2002
8	Neoplasms (Cancer) 03/2024 - 01/2006
8	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2022 - 01/2010
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022 - 07/2020
5	Hematologic Neoplasms (Hematological Malignancy) 12/2022 - 06/2010
4	Bronchiolitis Obliterans Syndrome 01/2024 - 01/2009
4	Disease Progression 01/2022 - 01/2016
3	Philadelphia Chromosome 11/2023 - 03/2015
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 03/2015
3	Infections 01/2023 - 01/2011
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 10/2019
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 01/2010
3	Acute Promyelocytic Leukemia 09/2020 - 12/2010
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2020 - 11/2003
2	Residual Neoplasm 11/2023 - 03/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2022 - 01/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2022 - 01/2009
2	Lymphopenia (Lymphocytopenia) 01/2022 - 11/2015
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2020 - 04/2018
2	Hemorrhage 03/2020 - 04/2018
2	Myelitis 12/2018 - 11/2010
2	Pain (Aches) 12/2018 - 11/2010
2	Encephalitis (Encephalitis, Rasmussen) 12/2018 - 11/2010
2	Primary Myelofibrosis (Myelosclerosis) 09/2017 - 01/2016
2	Essential Thrombocythemia 01/2017 - 01/2016
2	Neutropenia 11/2015 - 08/2014
2	Anemia 11/2015 - 01/2007
2	Pneumonia (Pneumonitis) 11/2015 - 10/2008
2	Hypoxia (Hypoxemia) 03/2013 - 10/2008
2	Hemorrhagic Cystitis 08/2012 - 03/2012
2	Aspergillosis 07/2011 - 06/2010
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 05/2024
1	Hemolysis 05/2024
1	Plasma Cell Neoplasms 03/2024
1	Virus Diseases (Viral Diseases) 01/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2024
1	Frailty 09/2023
1	Hereditary Angioedemas 07/2023

Drug/Important Bio-Agent (IBA)

11	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023 - 08/2014
6	Lenalidomide (CC 5013)FDA Link 09/2023 - 04/2017
6	Rituximab (Mabthera)FDA Link 12/2022 - 08/2012
5	mogamulizumabIBA 12/2022 - 03/2013
5	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2004
5	Bortezomib (Velcade)FDA Link 05/2020 - 01/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2004
5	Transcription Factors (Transcription Factor)IBA 08/2017 - 06/2004
4	Methotrexate (Mexate)FDA LinkGeneric 08/2022 - 01/2019
4	Tyrosine Kinase InhibitorsIBA 07/2020 - 03/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 10/2008
3	LigandsIBA 08/2022 - 06/2021
3	pomalidomideIBA 07/2022 - 01/2015
3	Gemcitabine FDA Link 11/2020 - 10/2019
3	Calcineurin InhibitorsIBA 11/2019 - 11/2010
3	Dasatinib (BMS 354825)FDA Link 01/2017 - 03/2015
3	Aprepitant (Emend)FDA Link 09/2013 - 01/2013
3	Melphalan (Alkeran)FDA LinkGeneric 09/2013 - 01/2013
3	proto-oncogene protein Spi-1IBA 01/2006 - 06/2004
2	Vincristine (Oncovin)FDA LinkGeneric 12/2022 - 01/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 03/2020
2	Bendamustine Hydrochloride FDA Link 01/2022 - 07/2017
2	Indicators and Reagents (Reagents)IBA 12/2020 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 10/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2020 - 09/2020
2	Immunomodulating AgentsIBA 05/2020 - 04/2017
2	Proteasome InhibitorsIBA 05/2020 - 04/2017
2	Inosine Triphosphate (ITP)IBA 03/2020 - 04/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019 - 01/2017
2	Methylprednisolone FDA LinkGeneric 11/2018 - 10/2008
2	Thalidomide (Thalomid)FDA Link 04/2017 - 08/2014
2	Janus Kinase 2IBA 01/2017 - 01/2016
2	nilotinib FDA Link 01/2017 - 01/2017
2	Monoclonal AntibodiesIBA 01/2016 - 03/2013
2	Mucin-3IBA 09/2015 - 12/2010
2	DefensinsIBA 10/2013 - 07/2012
2	AntiemeticsIBA 02/2013 - 01/2013
1	Pregnenolone Carbonitrile (PCN)IBA 03/2024
1	Circulating Tumor DNAIBA 03/2024
1	Peptides (Polypeptides)IBA 01/2024
1	HLA-B Antigens (HLA-B)IBA 01/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	ixazomibIBA 09/2023
1	ParaproteinsIBA 09/2023
1	PlasminogenIBA 07/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 03/2024 - 10/2009
14	Therapeutics 01/2023 - 01/2005
13	Stem Cell Transplantation 12/2021 - 07/2011
13	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2010
10	Transplantation 10/2021 - 10/2009
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 10/2008
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2021 - 01/2013
1	Plasma Exchange 05/2024
1	Extracorporeal Circulation 05/2024